Company: TYRA
Filing Date: 2025-05-08
Form Type: S-3
Source: 0001193125-25-116008
Chunk: 13

Company: Tyra Biosciences, Inc.
Filing Date: 2025-05-08
Form: S-3
Chunk 13
---
 board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of the common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control and may adversely affect the market price of the common stock and the voting and other rights of the holders of common stock. We will describe in a prospectus supplement relating to the class or series of preferred stock being offered the following terms:

| • |     | the title and stated value of the preferred stock; |

| • |     | the number of shares of the preferred stock offered, the liquidation preference per share and the offering price 
 of the preferred stock;                                                                                          |

| • |     | the dividend rate(s), period(s) or payment date(s) or method(s) of calculation applicable to the preferred stock; |

| • |     | whether dividends are cumulative or non-cumulative and, if cumulative, 
 the date from which dividends on the preferred stock will accumulate;  |

| • |     | the procedures for any auction and remarketing, if any, for the preferred stock; |

| • |     | the provisions for a sinking fund, if any, for the preferred stock; |

| • |     | the provision for redemption, if applicable, of the preferred stock; |

| • |     | any listing of the preferred stock on any securities exchange; |

| • |     | the terms and conditions, if applicable, upon which the preferred stock will be convertible into common stock, 
 including the conversion price or manner of calculation and conversion period;                                 |

| • |     | voting rights, if any, of the preferred stock; |

| • |     | a discussion of any material or special U.S. federal income tax considerations applicable to the preferred stock; |

| • |     | the relative ranking and preferences of the preferred stock as to dividend rights and rights upon the 
 liquidation, dissolution or winding up of our affairs;                                                |

10

| • |     | any limitations on issuance of any class or series of preferred stock ranking senior to or on a parity with the                     
 class or series of preferred stock as to dividend rights and rights upon liquidation, dissolution or winding up of our affairs; and |

| • |     | any other specific terms, preferences, rights, limitations or restrictions of the preferred stock. |